Main Article Content
Cancer remains a major of public health problem and leading cause of death worldwide. This cross-sectional analytical study aimed to identify factors associated with demand for medical cannabis (MC) use cancer patients in Chemotherapy unit, Sawanpracharak hospital, Nakhonsawan Province. Subjects were 214 cancer patients aged 18 or older in Chemotherapy unit, selected by multistage random sampling. The research instruments consisted of a 1) Demographic Data Recording Form, 2) Social Support Questionnaire, 3) Attitude about MC use Questionnaire, 4) Knowledge about MC Questionnaire, 5) Health literacy about MC use Questionnaire, and 6) Demand of MC use among cancer patients Questionnaire. The questionnaire was test by experts for validity was 0.97 for all questionnaires. The Cronbach’s Alpha of questionnaire were 0.88 for sociodemographic factors, 0.86 for social support, 0.81 for attitudes, and 0.94 for health literacy about MC use. The Kuder - Richardson was 0.75 for knowledge about MC questionnaires. Data were analyzed by using frequency, percentages, means, standard deviations, descriptive statistics, and multiple logistic regression.
The results demonstrated that the factors significantly associated with demand to use MC included had adequate- excellent health literacy about MC (ORadj=6.50; 95% CI: 3.14 to 13.45), positive attitudes toward MC use (ORadj = 5.88; 95% CI: 2.52 to 13.68), higher levels of social support (ORadj= 4.95; 95% CI: 2.29 to 10.66), higher levels of knowledge about MC (ORadj =3.32; 95% CI: 1.27 to 8.62) and male (ORadj=2.56; 95% CI: 1.23 to 5.33) when controlling effect of other covariates. Therefore, health literacy about MC use should be strengthened among cancer patients, along with promoting good attitudes, and knowledge about MC use as a complementary medicine to treat cancers.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
World Health Organization [Internet]. Cancer [cited 2021 Feb 23]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
กองยุทธศาสตร์และแผนงาน สำนักงานปลัดกระทรวงสาธารณสุข. (2563). สถิติสาธารณสุข พ.ศ. 2562. กรุงเทพฯ: ผู้เขียน.
American Cancer Society (2016). Cancer Treatment and Survivorship Facts and Figures 2016-2017. Available at: cancer-treatment-and-survivorship-facts-andfigures-2016-2017.pdf Accessed on 27/04/2021.
Blake A, Wan BA, Malek L, et al. A selective review of medical cannabis in cancer pain management. Ann Palliat Med. 2017;6(Suppl 2): S215-S222.
Klumpers LE, Thacker DL. A Brief Background on Cannabis: From Plant to Medical Indications. J AOAC Int. 2019;102(2):412-420.
Amin MR, Ali DW. Pharmacology of Medical Cannabis. Adv Exp Med Biol. 2019; 1162:151-165.
Lal S, Shekher A, Puneet, Narula AS, Abrahamse H, Gupta SC. Cannabis, and its constituents for cancer: History, biogenesis, chemistry, and pharmacological activities. Pharmacol Res. 2021; 163:105302.
เพชร อลิสานันท์. การปลดล็อคกัญชาทางการแพทย์กับสังคมไทย. วารสารมะเร็งวิวัฒน์. 2562. 123-130. Retrieved from http://www.chulacancer.net/uploads/articles_attc/1552277306.pdf
Webster EM, Yadav GS, Gysler S, et al. Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study. Gynecol Oncol Rep. 2020; 34:100667. Published 2020 Nov 2.
Labidi S, Ennouri S, Rachdi H, et al. Use of complementary and alternative medicine in cancer: A Tunisian single-center experience. Bull Cancer. 2020;107(2):209-214.
Barner JC, Bohman TM, Brown CM, Richards KM. Use of complementary and alternative medicine for treatment among African-Americans: a multivariate analysis. Res Social Adm Pharm. 2010;6(3):196-208.
Jones E, Nissen L, McCarthy A, Steadman K, Windsor C. Exploring the Use of Complementary and Alternative Medicine in Cancer Patients [retracted in: Integr Cancer Ther. 2020 Jan-Dec; 19:1534735420907179]. Integr Cancer Ther. 2019; 18:1534735419854134.
Loquai C, Dechent D, Garzarolli M, et al. Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients. Eur J Cancer. 2017; 71:70-79.
Bauml JM, Chokshi S, Schapira MM, et al. Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey. Cancer. 2015;121(14):2431-2438.
Gazibara T, Prpic M, Maric G, Pekmezovic T, Kisic-Tepavcevic D. Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult Population. J Psychoactive Drugs. 2017;49(3):217-224.
Sukrueangkul A, Panomai N, Laohasiriwong W, Sakphisutthikul C, Phimha S. Factors Influencing Demand for Medical Cannabis Use among Cancer Patients in the North of Thailand. Asian Pac J Cancer Prev. 2022;23(1):319-325.
Sørensen K, Van den Broucke S, Fullam J, et al. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health. 2012; 12:80.
Sørensen K, Van den Broucke S, Pelikan JM, et al. Measuring health literacy in populations: illuminating the design and development process of the European Health Literacy Survey Questionnaire (HLS-EU-Q). BMC Public Health. 2013; 13:948. Published 2013 Oct 10.
Martell K, Fairchild A, LeGerrier B, et al. Rates of cannabis use in patients with cancer. Curr Oncol. 2018;25(3):219-225.
Sukrueangkul A, Phimha S, Panomai N, Laohasiriwong W, Sakphisutthikul C. Attitudes and Beliefs of Cancer Patients Demanding Medical Cannabis Use in North Thailand. Asian Pac J Cancer Prev. 2022;23(4):1309-1314.
Zhang Y, Leach MJ, Hall H, et al. Differences between Male and Female Consumers of Complementary and Alternative Medicine in a National US Population: A Secondary Analysis of 2012 NIHS Data. Evid Based Complement Alternat Med. 2015; 2015:413173.
Evans M, Shaw A, Thompson EA, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med. 2007; 7:25.
Troutt WD, DiDonato MD. Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization. J Psychoactive Drugs. 2015;47(4):259-266.